EUVIMEDEUVIMED entdecken
Crossref

Rational Design, Green Synthesis, and Biological Evaluation of Novel Imidazole Derivatives as Potent EGFR Inhibitors via One‐Pot Four‐Component Reaction

Alaa Muqbil Alsirhani, Ibtisam Aali iD, Modather F Hussein, Nadia A A Elkanzi iD, Ali M Ali iD, Moustafa O Aboelez iD

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.70044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Alaa Muqbil Alsirhani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Science, Jouf University, Sakaka, Aljouf, Saudi Arabia. Hauptthemen laut MEDLINE: Imidazoles, Antineoplastic Agents, Protein Kinase Inhibitors, Drug Design. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: This study was funded by the Deanship of Graduate Studies and Scientific Research at Jouf University under grant No. (DGSSR-2024-02-02166)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study reports a green, efficient, and high‐yielding synthesis of novel imidazole derivatives 5a – i via a one‐pot, four‐component reaction under microwave irradiation. The optimized protocol demonstrates satisfactory yields (86%–92%), short reaction times (9–14 min), easy workup, and avoidance of toxic solvents, in accordance with sustainable chemistry principles. The antiproliferative efficacy of derivatives 5a – i was evaluated against H1975, A549, and A431 cells, using the MTT assay. The results indicated that derivatives 5b and 5g exhibited the greatest antiproliferative activity, with IC 50 values of 5.22 and 6.34 µM. The values obtained were markedly inferior to those of recognized EGFR inhibitors, such as osimertinib, gefitinib, and erlotinib. Compound 5b was exhibited as the most potent inhibitor of both EGFR WT and EGFR T790M kinases, with IC 50 values of 30.1 and 12.8 nM, respectively. The findings exceeded those of osimertinib and gefitinib, which demonstrated IC 50 values of 54.3, 19.1, 9.1, and 356.8 nM, respectively, which may explain its notable antiproliferative effect against the H1975 cell line. Molecular docking and dynamics simulations confirmed the stable binding of derivatives 5b and 5g within the EGFR active sites, aligning with experimental findings. Furthermore, in silico ADME properties for the promising EGFR inhibitors 5b and 5g , conducted using the egg‐boiled technique, demonstrated favorable lipophilicity, G.I.T. absorption, and BBB permeability. As a result, imidazoles 5a–i , particularly 5b and 5g , exhibited promising antiproliferative properties, targeting EGFR WT and EGFR T790M kinase inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImidazolesAntineoplastic AgentsProtein Kinase InhibitorsDrug DesignHumansErbB ReceptorsCell ProliferationStructure-Activity RelationshipCell Line, TumorMolecular Docking SimulationDrug Screening Assays, AntitumorMolecular StructureDose-Response Relationship, DrugGreen Chemistry TechnologyInhibitory Concentration 50Microwaves

Stichwörter der Autor:innen

EGFRT790MEGFRWTSwiss ADME predictionimidazolesin silico studymicrowave irradiationrational design

Substanzen

ErbB ReceptorsImidazolesAntineoplastic AgentsProtein Kinase InhibitorsEGFR protein, human

Autor:innen und Institutionen

  • Department of Chemistry, College of Science, Jouf University, Sakaka, Aljouf, Saudi Arabia.
  • Chemistry Department, Faculty of Science, Sohag University, Sohag, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University, Sohag, Egypt.

ORCID-Profile: Ibtisam Aali, Nadia A A Elkanzi, Ali M Ali, Moustafa O Aboelez

Förderung

  • This study was funded by the Deanship of Graduate Studies and Scientific Research at Jouf University under grant No. (DGSSR-2024-02-02166).

Zitieren

APA

Alsirhani, A. M., Aali, I., Hussein, M. F., Elkanzi, N. A. A., Ali, A. M., & Aboelez, M. O. (2025). Rational Design, Green Synthesis, and Biological Evaluation of Novel Imidazole Derivatives as Potent EGFR Inhibitors via One‐Pot Four‐Component Reaction. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70044

Vancouver

Alsirhani AM, Aali I, Hussein MF, Elkanzi NAA, Ali AM, Aboelez MO. Rational Design, Green Synthesis, and Biological Evaluation of Novel Imidazole Derivatives as Potent EGFR Inhibitors via One‐Pot Four‐Component Reaction. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70044

BibTeX
@article{Alsirhani2025,
  author = {Alsirhani, Alaa Muqbil and Aali, Ibtisam and Hussein, Modather F and Elkanzi, Nadia A A and Ali, Ali M and Aboelez, Moustafa O},
  title = {Rational Design, Green Synthesis, and Biological Evaluation of Novel Imidazole Derivatives as Potent EGFR Inhibitors via One‐Pot Four‐Component Reaction},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.70044}
}
Kostenlos starten →